5. Tomlin J, Chang D, McCutcheon B, Harris J. Surgical technique and
recurrence in cholesteatoma: a meta-analysis.
Audiol Neurootol
2013;18:
135–142.
6. Brown JS. A ten year statistical follow-up of 1142 consecutive cases of cho-
lesteatoma: the closed vs. the open technique.
Laryngoscope
1982;92:
390–396.
7. Nyrop M, Bonding P. Extensive cholesteatoma: Long-term results of three
surgical techniques.
J Laryngol Otol
1997;111:521–526.
8. Kos MI, Castrillon R, Montandon P, Guyot JP. Anatomic and functional
long-term results of canal wall-down mastoidectomy.
Ann Otol Rhinol
Laryngol
2004;113:872–876.
9. Jackler RK. The surgical anatomy of cholesteatoma.
Otolaryngol Clin
North Am
1989;22:883–896.
10. Neudert M, Lailach S, Lasurashvili N, Kemper M, Beleites T, Zahnert T.
Cholesteatoma recidivism: comparison of three different surgical techni-
ques.
Otol Neurotol
2014;35:1801–1808.
11. Kuo CL, Liao WH, Shiao AS. A review of current progress in acquired cho-
lesteatoma management.
Eur Arch Otorhinolaryngol.
2014. Epub ahead
of print.
12. Abramson M, Lachenbruch PA, Press BH, McCabe BF. Results of conservative
surgery for middle ear cholesteatoma.
Laryngoscope
1977;87:1281–1287.
13. Yang WY, Watson C. Post-operative follow up of cholesteatoma-how long is
adequate?
Clin Otolaryngol
2012;37:160.
14. Lau T, Tos M. Tensa retraction cholesteatoma: treatment and long-term
results.
J Laryngol Otol
1989;103:149–157.
15. Stankovic M. Follow-up of cholesteatoma surgery: open versus closed tym-
panoplasty.
ORL J Otorhinolaryngol Relat Spec
2007;69:299–305.
16.
Cochrane Handbook
. 9.5.2 identifying and measuring heterogeneity.
http:// handbook.cochrane.org/chapter_9/9_5_2_identifying_and_measuring_het- erogeneity.htm. Accessed January 13, 2015.
17. Charachon R, Roux O, Eyraud S. Cholesteatoma of the middle ear. Choice
of technique and results in the adult and child.
Ann Otolaryngol Chir
Cervicofac
1980;97:65–78.
18. Roden D, Honrubia VF, Wiet R. Outcome of residual cholesteatoma and
hearing in mastoid surgery.
J Otolaryngol
1996;25:178–181.
19. Ajalloueyan M. Surgery in cholesteatoma: ten years follow-up.
Iran J Med
Sci
2006;31:37–40.
20. Palmgren O. Long-term results of open cavity and tympanomastoid sur-
gery of the chronic ear.
Acta Otolaryngol
1979;88:343–349.
21. House WF, Sheehy JL. Functional restoration in tympanoplasty.
Arch Oto-
laryngol
1963;78:304–309.
22. Quaranta A, Cassano P, Carbonara G. Cholesteatoma surgery: Open vs
closed tympanoplasty.
Am J Otol
1988;9:229–231.
23. Ikeda M, Yoshida S, Ikui A, Shigihara S. Canal wall down tympanoplasty
with canal reconstruction for middle-ear cholesteatoma: post-
operative hearing, cholesteatoma recurrence, and status of re-
aeration of reconstructed middle-ear cavity.
J Laryngol Otol
2003;117:
249–255.
24. Gerlach H. Is the “second look” justified after cholesteatoma surgery
according to the closed technique? (our concept of “indicator-pearl”).
Lar-
yngol Rhinol Otol (Stuttg)
1982;61:294–296.
25. Elefante A, Cavaliere M, Russo C, et al. Diffusion weighted MR imaging
of primary and recurrent middle ear cholesteatoma: an assessment
by readers with different expertise.
Biomed Res Int
2015;2015:597896.
26. Quaranta N, Iannuzzi L, Petrone P, D’Elia A, Quaranta A. Quality of life
after cholesteatoma surgery: intact-canal wall tympanoplasty versus
canal wall-down tympanoplasty with mastoid obliteration.
Ann Otol Rhi-
nol Laryngol
2014;123:89–93.
27. Vartiainen E. Factors associated with recurrence of cholesteatoma.
J Laryngol Otol
1995;109:590–592.
28. Lynrah ZA, Bakshi J, Panda NK, Khandelwal NK. Aggressiveness of pedi-
atric cholesteatoma. Do we have an evidence?
Indian J Otolaryngol
Head Neck Surg
2013;65:264–268.
29. Stapleton AL, Egloff AM, Yellon RF. Congenital cholesteatoma: predictors
for residual disease and hearing outcomes.
Arch Otolaryngol Head Neck
Surg
2012;138:280–285.
30. Visvanathan V, Kubba H, Morrissey MS. Cholesteatoma surgery in chil-
dren: 10-year retrospective review.
J Laryngol Otol
2012;126:450–453.
31. Ahn SH, Oh SH, Chang SO, Kim CS. Prognostic factors of recidivism in
pediatric cholesteatoma surgery.
Int J Pediatr Otorhinolaryngol
2003;67:
1325–1330.
32. Lazard DS, Roger G, Denoyelle F, Chauvin P, Garabedian EN. Congenital
cholesteatoma: risk factors for residual disease and retraction pockets—
a report on 117 cases.
Laryngoscope
2007;117:634–637.
33. Stangerup SE, Drozdziewicz D, Tos M. Cholesteatoma in children, predic-
tors and calculation of recurrence rates.
Int J Pediatr Otorhinolaryngol
1999;49(suppl 1):S69–S73.
34. Roger G, Denoyelle F, Chauvin P, Schlegel-Stuhl N, Garabedian EN. Pre-
dictive risk factors of residual cholesteatoma in children: a study of 256
cases.
Am J Otol
1997;18:550–558.
35. Iino Y, Imamura Y, Kojima C, Takegoshi S, Suzuki JI. Risk factors for
recurrent and residual cholesteatoma in children determined by second
stage operation.
Int J Pediatr Otorhinolaryngol
1998;46:57–65.
36. Roux A, Bakhos D, Lescanne E, Cottier JP, Robier A. Canal wall recon-
struction in cholesteatoma surgeries: rate of residual.
Eur Arch Otorhi-
nolaryngol
2014. Epub ahead of print.
37. Muir Gray, JA. Evidence-Based Healthcare and Public Health: How to
Make Decisions About Health Services and Public Health. Edinburgh,
Scotland; New York, NY: Churchill Livingstone/Elsevier; 2009.
Laryngoscope 126: April 2016
Kerckhoffs et al.: A Review on Cholesteatoma Recidivism After CWU and CWD
112




